Return to Search
EN
While classical chemotherapy applications remain important in cancer treatment, innovative methods such as targeted drugs, immunotherapies, and molecular therapies significantly increase treatment success rates.
Targeted Smart Drugs
These drugs aim to halt tumor development by specifically inhibiting the growth signals of cancer cells. Designed as small molecules or antibodies, they exert their effect by binding to the growth receptors of cancer cells. They can be administered both orally as pills and intravenously. With minimal or controllable side effects such as nausea and hair loss, these drugs offer an effective treatment option for patients and improve their quality of life during the treatment process. They are used in many types of cancer, especially brain tumors, head and neck, lung, stomach, breast, kidney, and prostate cancers. Targeted drugs do not replace classical chemotherapies but are applied as part of combined treatments in certain cancer types.
Immunotherapy
This treatment method aims to activate or direct the body's own immune system to fight cancer. It supports the treatment of the disease by increasing the activation of naturally occurring cancer-fighting cells in the human body or by directing them to cancer tissue. It is generally administered intravenously as a serum at 2-3 week intervals. In addition to providing highly effective results in malignant melanoma and lung cancer, it is also successfully used in various cancer types such as kidney and lymph cancers.
Molecular and Radiomolecular Therapies
For patients who are not candidates for surgery or have widespread tumors, molecular and radiomolecular therapies offer important alternatives that extend life expectancy and improve quality of life. These treatments use molecules that target the specific characteristics or vulnerabilities of cancer cells. When administered orally or intravenously, they reach the cancerous area, minimizing effects on healthy tissues while destroying tumor cells.
* Yttrium-90 Microsphere Therapy: In liver tumors, microscopic radioactive "yttrium-90" containing beads are delivered directly to the tumor, providing high-energy radiation that leads to tumor regression and extended survival.
* Radioactive Peptide Therapies (Actinium, Lutetium, etc.): These are highly effective options for conditions such as neuroendocrine tumors (which can originate from the stomach, pancreas, bowel, thyroid, lung) and advanced prostate cancer. Intravenously administered radioactive peptides attach to target cells, emitting a high amount of localized radiation and destroying cancerous cells. These methods have the potential to halt disease progression in patients where surgery is not feasible.
* Radioactive Iodine (Atom) Therapy: This is a widely used radionuclide therapy in the treatment of thyroid cancers. It is mostly administered orally as a capsule or liquid after surgery.
What are the types of chemotherapy drugs?
Targeted Smart Drugs
These drugs aim to halt tumor development by specifically inhibiting the growth signals of cancer cells. Designed as small molecules or antibodies, they exert their effect by binding to the growth receptors of cancer cells. They can be administered both orally as pills and intravenously. With minimal or controllable side effects such as nausea and hair loss, these drugs offer an effective treatment option for patients and improve their quality of life during the treatment process. They are used in many types of cancer, especially brain tumors, head and neck, lung, stomach, breast, kidney, and prostate cancers. Targeted drugs do not replace classical chemotherapies but are applied as part of combined treatments in certain cancer types.
Immunotherapy
This treatment method aims to activate or direct the body's own immune system to fight cancer. It supports the treatment of the disease by increasing the activation of naturally occurring cancer-fighting cells in the human body or by directing them to cancer tissue. It is generally administered intravenously as a serum at 2-3 week intervals. In addition to providing highly effective results in malignant melanoma and lung cancer, it is also successfully used in various cancer types such as kidney and lymph cancers.
Molecular and Radiomolecular Therapies
For patients who are not candidates for surgery or have widespread tumors, molecular and radiomolecular therapies offer important alternatives that extend life expectancy and improve quality of life. These treatments use molecules that target the specific characteristics or vulnerabilities of cancer cells. When administered orally or intravenously, they reach the cancerous area, minimizing effects on healthy tissues while destroying tumor cells.
* Yttrium-90 Microsphere Therapy: In liver tumors, microscopic radioactive "yttrium-90" containing beads are delivered directly to the tumor, providing high-energy radiation that leads to tumor regression and extended survival.
* Radioactive Peptide Therapies (Actinium, Lutetium, etc.): These are highly effective options for conditions such as neuroendocrine tumors (which can originate from the stomach, pancreas, bowel, thyroid, lung) and advanced prostate cancer. Intravenously administered radioactive peptides attach to target cells, emitting a high amount of localized radiation and destroying cancerous cells. These methods have the potential to halt disease progression in patients where surgery is not feasible.
* Radioactive Iodine (Atom) Therapy: This is a widely used radionuclide therapy in the treatment of thyroid cancers. It is mostly administered orally as a capsule or liquid after surgery.